{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:29:45Z","timestamp":1790339385168,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,2,24]],"date-time":"2010-02-24T00:00:00Z","timestamp":1266969600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1208\/s12249-009-9368-1","type":"journal-article","created":{"date-parts":[[2010,2,23]],"date-time":"2010-02-23T22:01:19Z","timestamp":1266962479000},"page":"285-293","source":"Crossref","is-referenced-by-count":4,"title":["Composition Optimization and Stability Testing of a Parenteral Antifungal Solution based on a Ternary Solvent System"],"prefix":"10.1208","volume":"11","author":[{"given":"Krist\u00f3f","family":"Kov\u00e1cs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n","family":"Antal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6rgy","family":"Stampf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imre","family":"Klebovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krisztina","family":"Lud\u00e1nyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,2,24]]},"reference":[{"key":"9368_CR1","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1021\/js980051i","volume":"87","author":"SH Yalkowsky","year":"1998","unstructured":"Yalkowsky SH, Krzyzaniak JF, Ward GH. Formulation-related problems associated with intravenous drug delivery. J Pharm Sci. 1998;87:787\u201396.","journal-title":"J Pharm Sci"},{"key":"9368_CR2","unstructured":"Egger-Heigold B. The effect of excipients on pharmacokinetic parameters of parenteral drugs (dissertation). Basel; 2005."},{"key":"9368_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0378-5173(96)04545-0","volume":"140","author":"S Torrado","year":"1996","unstructured":"Torrado S, Torrado S, Cadorniga R, Torrado JJ. Formulation parameters of albendazole solution. Int J Pharm. 1996;140:45\u201350.","journal-title":"Int J Pharm"},{"key":"9368_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0378-5173(99)00129-5","volume":"185","author":"FA Alvarez-N\u00fa\u00f1ez","year":"1999","unstructured":"Alvarez-N\u00fa\u00f1ez FA, Yalkowsky SH. Buffer capacity and precipitation control of pH solubilized phention formulations. Int J Pharm. 1999;185:45\u20139.","journal-title":"Int J Pharm"},{"issue":"5","key":"9368_CR5","first-page":"330","volume":"50","author":"S Sweetana","year":"1999","unstructured":"Sweetana S, Akers MJ. Solubility principles and practice for parenteral drug dosage form development. PDA J Pharm Sci Tech. 1999;50(5):330\u201342.","journal-title":"PDA J Pharm Sci Tech"},{"key":"9368_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0378-5173(02)00318-6","volume":"244","author":"N Ni","year":"2002","unstructured":"Ni N, Sanghvi T, Yalkowsky SH. Solubilization and preformulation of carbendazim. Int J Pharm. 2002;244:99\u2013104.","journal-title":"Int J Pharm"},{"issue":"2","key":"9368_CR7","first-page":"147","volume":"8","author":"CO Rangel-Yagui","year":"2005","unstructured":"Rangel-Yagui CO, Pessoa-Jr A, Tavares LC. Micellar solubilization of drugs. J Pharm Pharmaceut Sci. 2005;8(2):147\u201363.","journal-title":"J Pharm Pharmaceut Sci"},{"key":"9368_CR8","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ijpharm.2005.10.004","volume":"307","author":"MC Lamas","year":"2006","unstructured":"Lamas MC, Villaggi L, Nocito I, Bassani G, Leonardi D, Pascutti F, et al. Development of parenteral formulations and evaluation of the biological activity of the trypanocide drug benznidazole. Int J Pharm. 2006;307:239\u201343.","journal-title":"Int J Pharm"},{"key":"9368_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1046\/j.1365-2710.2000.00285.x","volume":"25","author":"HS Lin","year":"2000","unstructured":"Lin HS, Chean CS, Ng YY, Chan SY, Ho PC. 2-Hydroxypropyl-\u03b2-cyclodextrin increases aqueous solubility and photostability of all-trans-retinoic acid. J Clin Pharm Ther. 2000;25:265\u20139.","journal-title":"J Clin Pharm Ther"},{"key":"9368_CR10","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1021\/js970315l","volume":"87","author":"GA Brazeau","year":"1998","unstructured":"Brazeau GA, Cooper B, Svetic KA, Smith CL, Gupta P. Current perspectives on pain upon injection of drugs. J Pharm Sci. 1998;87:667\u201377.","journal-title":"J Pharm Sci"},{"key":"9368_CR11","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0378-5173(97)00082-3","volume":"52","author":"JF Kryzaniak","year":"1997","unstructured":"Kryzaniak JF, Raymond DM, Yalkowsky SH. Lysis of human red blood cells 2: effect of contact time on cosolvent induced hemolysis. Int J Pharm. 1997;52:193\u2013200.","journal-title":"Int J Pharm"},{"key":"9368_CR12","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1002\/jps.20627","volume":"95","author":"K Amin","year":"2006","unstructured":"Amin K, Dannenfelser RM. In vitro hemolysis: guidance for the pharmaceutical scientist. J Pharm Sci. 2006;95:1173\u20136.","journal-title":"J Pharm Sci"},{"key":"9368_CR13","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1021\/js970184o","volume":"86","author":"JF Krzyzaniak","year":"1997","unstructured":"Krzyzaniak JF, Alvarez Nunez FA, Raymond DM, Yalkowsky SH. Lysis of human red blood cells. 4. Comparison of in vitro and in vivo hemolysis data. J Pharm Sci. 1997;86:1215\u20137.","journal-title":"J Pharm Sci"},{"key":"9368_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3109\/10731199509117673","volume":"23","author":"K Lowe","year":"1995","unstructured":"Lowe K, Furmidge B, Thomas S. Haemolytic properties of pluronic surfactants and effects of purification. Artif Cell Blood Substit Immobil Biotechnol. 1995;23:135\u20139.","journal-title":"Artif Cell Blood Substit Immobil Biotechnol"},{"key":"9368_CR15","first-page":"161","volume":"53","author":"H Al-Assadi","year":"1989","unstructured":"Al-Assadi H, Baillie AJ, Florence AT. The haemolytic activity of non-ionic surfactants. Int J Pharm. 1989;53:161.","journal-title":"Int J Pharm"},{"key":"9368_CR16","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/adma.19910030507","volume":"3","author":"JG Riess","year":"1991","unstructured":"Riess JG, Pace S, Zarif L. Highly effective surfactants with low hemolytic activity. Adv Mat. 1991;3:249\u201351.","journal-title":"Adv Mat"},{"key":"9368_CR17","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/BF02641003","volume":"70","author":"M Ohnishi","year":"1993","unstructured":"Ohnishi M, Sagitani H. The effect of nonionic surfactant structure on hemolysis. J Am Oil Chem Soc. 1993;70:679\u201384.","journal-title":"J Am Oil Chem Soc"},{"key":"9368_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1365-2710.2005.00669.x","volume":"30","author":"B Pourroy","year":"2005","unstructured":"Pourroy B, Botta C, Solas C, Lacarelle B, Braguer D. Seventy-two-hour stability of Taxol\u00ae in 5% dextrose or 0.9% sodium chloride in Viaflo\u00ae, Freeflex\u00ae, Ecoflac\u00ae and Macoflex N\u00ae non-PVC bags. J Clin Pharm Ther. 2005;30:155\u2013458.","journal-title":"J Clin Pharm Ther"},{"key":"9368_CR19","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1365-2710.1987.tb00558.x","volume":"12","author":"AG McGookin","year":"1989","unstructured":"McGookin AG, Millership JS, Scott EM. Miconazole sorption to intravenous infusion sets. J Clin Pharm Ther. 1989;12:433\u20137.","journal-title":"J Clin Pharm Ther"},{"key":"9368_CR20","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.ejps.2008.10.007","volume":"36","author":"K Kov\u00e1cs","year":"2009","unstructured":"Kov\u00e1cs K, Stampf Gy, Klebovich I, Antal I, Lud\u00e1nyi K. Aqueous solvent system for the solubilization of azole compounds. Eur J Pharm Sci. 2009;36:352\u20138.","journal-title":"Eur J Pharm Sci"},{"key":"9368_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0378-5173(98)00103-3","volume":"169","author":"G Piel","year":"1998","unstructured":"Piel G, Evrard B, Fillet M, Llabres G, Delattre L. Development of a non-surfactant parenteral formulation of miconazole by the use of cyclodextrins. Int J Pharm. 1998;169:15\u201322.","journal-title":"Int J Pharm"},{"key":"9368_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1023\/B:JIPH.0000003875.46691.f6","volume":"47","author":"F Taneri","year":"2003","unstructured":"Taneri F, G\u00fcneri T, Aigner Z, Kata M. Influence of cyclodextrin complexation on the physicochemical and biopharmaceutical properties of ketoconazole. J Incl Phenom Macro Chem. 2003;47:15\u201323.","journal-title":"J Incl Phenom Macro Chem"},{"key":"9368_CR23","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/S0959-8049(01)00171-X","volume":"37","author":"H Gelderblom","year":"2001","unstructured":"Gelderblom H, Verweij J, Nooter K, Sparreboom A. Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur J Cancer. 2001;37:1590\u20138.","journal-title":"Eur J Cancer"},{"key":"9368_CR24","first-page":"86","volume":"48","author":"SL Gupta","year":"1994","unstructured":"Gupta SL, Patel JP, Jones DL, Partipilo RW. Parenteral formulation development of renin inhibitor Abbott-72517. PDA J Pharm Sci Tech. 1994;48:86\u201391.","journal-title":"PDA J Pharm Sci Tech"},{"key":"9368_CR25","first-page":"378","volume":"7","author":"V Barillaro","year":"2004","unstructured":"Barillaro V, Bertholet P, de Hassonville SH. Effect of acidic ternary compounds on the formation of miconazole\/cyclodextrin inclusion complexes by means of supercritical carbon dioxide. J Pharm Pharmaceut Sci. 2004;7:378\u201388.","journal-title":"J Pharm Pharmaceut Sci"},{"key":"9368_CR26","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1046\/j.0269-4727.2003.00503.x","volume":"28","author":"IM Crane","year":"2003","unstructured":"Crane IM, Mulhern MG, Nema S. Stability of reconstituted parecoxib for injection with commonly used diluents. J Clin Pharm Ther. 2003;28:363\u20139.","journal-title":"J Clin Pharm Ther"},{"issue":"3","key":"9368_CR27","doi-asserted-by":"publisher","first-page":"article 14","DOI":"10.1208\/pt020314","volume":"2","author":"G Krishna","year":"2001","unstructured":"Krishna G, Hodnick WF, Lang W, Lin X, Karra S, Mao J, et al. Pharmaceutical development and manufacturing of a parenteral formulation of a novel antitumor agent, VNP40101M. AAPS PharmsciTech. 2001;2(3):article 14.","journal-title":"AAPS PharmsciTech"},{"key":"9368_CR28","unstructured":"Guideline on stability testing: stability testing of existing active substances and related finished products (CPMP\/QWP\/122\/02)"},{"key":"9368_CR29","doi-asserted-by":"publisher","unstructured":"Amin K, Dannenfelser RM. In vitro hemolysis: guidance for the pharmaceutical scientist. Wiley InterScience. 2007. doi: \n                    10.1002\/jps.20627\n                    \n                  .","DOI":"10.1002\/jps.20627"},{"key":"9368_CR30","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0378-5173(97)00082-3","volume":"152","author":"JF Krzyzaniak","year":"1997","unstructured":"Krzyzaniak JF, Raymond DM, Yalkowsky SH. Lysis of human red blood cells 2 effect of contact time on cosolvent induced hemolysis. Int J Pharm. 1997;152:193\u2013200.","journal-title":"Int J Pharm"},{"key":"9368_CR31","first-page":"66","volume":"52","author":"JF Krzyzaniak","year":"1998","unstructured":"Krzyzaniak JF, Raymond DM, Yalkowsky SH. Lysis of human red blood cells 3 effect of contact time on surfactant induced hemolysis. J Pharm Sci Technol. 1998;52:66\u20139.","journal-title":"J Pharm Sci Technol"},{"key":"9368_CR32","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1021\/mp049964d","volume":"1","author":"BP Ross","year":"2004","unstructured":"Ross BP, Braddy AC, McGeary RP, Blanchfield JT, Prokai L, Toth I. Micellar aggregation and membrane partitioning of bile salts, fatty acids, sodium dodecyl sulfate, and sugar-conjugated fatty acids: Correlation with hemolytic potency and implications for drug delivery. Mol Pharm. 2004;1:233\u201345.","journal-title":"Mol Pharm"},{"key":"9368_CR33","volume-title":"Solubility and solubilization in aqueous media","author":"SH Yalkowsky","year":"1999","unstructured":"Yalkowsky SH. Solubility and solubilization in aqueous media. New York: Oxford University Press; 1999."},{"key":"9368_CR34","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1556\/JPC.21.2008.2.12","volume":"21","author":"G V\u00f6lgyi","year":"2008","unstructured":"V\u00f6lgyi G, De\u00e1k K, V\u00e1mos J, Valk\u00f3 K, Tak\u00e1cs-Nov\u00e1k K. RPTLC determination of log P of structurally diverse neutral compounds. J Planar Chrom. 2008;21:143\u20139.","journal-title":"J Planar Chrom"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-009-9368-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-009-9368-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-009-9368-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-009-9368-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T03:48:08Z","timestamp":1559620088000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-009-9368-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,24]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["9368"],"URL":"https:\/\/doi.org\/10.1208\/s12249-009-9368-1","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,24]]}}}